ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,752.54
0.12%
Dow Jones
42,354.63
0.43%
US Dollar vs MXN
19.63363
0.05%
Brent Oil
70.785
-0.23%
Bitcoin
65,684.41
0.77%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Exagen Inc (XGN)

  7. Exagen Inc (XGN) Noticias

XGN

Exagen (XGN)

Exagen Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:XGN
FechaHoraFuenteTítuloSímboloCompañía
04/09/202417:12Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XGNExagen Inc
04/09/202417:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
04/09/202415:05GlobeNewswire Inc.Exagen Inc. to Participate in the 2024 Cantor Global Healthcare ConferenceNASDAQ:XGNExagen Inc
09/08/202416:08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XGNExagen Inc
05/08/202408:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XGNExagen Inc
05/08/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
05/08/202407:00GlobeNewswire Inc.Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record PerformanceNASDAQ:XGNExagen Inc
02/08/202416:20Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:XGNExagen Inc
02/08/202408:00GlobeNewswire Inc.Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:XGNExagen Inc
01/08/202408:00GlobeNewswire Inc.Exagen Appoints Jeffrey G. Black as New Chief Financial OfficerNASDAQ:XGNExagen Inc
22/07/202408:00GlobeNewswire Inc.Exagen to Announce Second Quarter 2024 Results on August 5, 2024NASDAQ:XGNExagen Inc
14/05/202415:25AllPennyStocks.comHealthcare Shares Soar Following Major Price Target IncreaseNASDAQ:XGNExagen Inc
13/05/202408:30Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:XGNExagen Inc
13/05/202407:00GlobeNewswire Inc.Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full YearNASDAQ:XGNExagen Inc
06/05/202415:05GlobeNewswire Inc.Exagen Announces Campaign for Lupus Awareness MonthNASDAQ:XGNExagen Inc
30/04/202415:05GlobeNewswire Inc.Exagen to Announce First Quarter 2024 Results on May 13, 2024NASDAQ:XGNExagen Inc
26/04/202407:30GlobeNewswire Inc.Exagen Inc. Announces Changes to the Board of DirectorsNASDAQ:XGNExagen Inc
18/03/202407:00GlobeNewswire Inc.Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 ResultsNASDAQ:XGNExagen Inc
18/03/202406:12IH Market NewsAnticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See UpticksNASDAQ:XGNExagen Inc
08/03/202408:00GlobeNewswire Inc.Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor ForumNASDAQ:XGNExagen Inc
07/03/202415:05GlobeNewswire Inc.Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024NASDAQ:XGNExagen Inc
14/02/202406:12Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XGNExagen Inc
30/01/202415:05GlobeNewswire Inc.Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASDAQ:XGNExagen Inc
07/01/202411:00GlobeNewswire Inc.Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms GuidanceNASDAQ:XGNExagen Inc
29/11/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XGNExagen Inc
29/11/202316:11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:XGNExagen Inc
27/11/202315:05Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:XGNExagen Inc
17/11/202315:06Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:XGNExagen Inc
13/11/202315:05GlobeNewswire Inc.Exagen Inc. Reports Strong Third Quarter 2023 ResultsNASDAQ:XGNExagen Inc
09/11/202315:05GlobeNewswire Inc.Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis BiomarkersNASDAQ:XGNExagen Inc
 Showing the most relevant articles for your search:NASDAQ:XGN

Su Consulta Reciente

BIT
F34776
Vontobel Financial Produ...
TG
A3K9NA
Coface
TG
OE8D
Kingdom of Spain
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados